Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
暂无分享,去创建一个
Lipika R. Pal | S. Chanda | E. Ruppin | L. Riva | Laura Martin-Sancho | N. Nair | K. Cheng | Xin Yin | S. Sinha | Yuan Pu | Kuoyuan Cheng | Sanju Sinha
[1] E. Graviss,et al. Risk factors for severity of COVID-19 in hospital patients age 18–29 years , 2021, PloS one.
[2] T. Spector,et al. Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study , 2021, The Lancet Digital Health.
[3] Jennifer G. Abelin,et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs , 2021, Cell.
[4] Mary K. Lewinski,et al. Functional landscape of SARS-CoV-2 cellular restriction , 2021, Molecular Cell.
[5] Evan T. Sholle,et al. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions , 2021, Nature Communications.
[6] Shane O’Carroll,et al. Targeting immunometabolism to treat COVID-19 , 2021, Immunotherapy advances.
[7] C. Demirdover. COVID-19-vaccines , 2021, Reactions Weekly.
[8] Minoru Kanehisa,et al. KEGG: integrating viruses and cellular organisms , 2020, Nucleic Acids Res..
[9] Silva Kasela,et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells , 2020, Cell.
[10] Peter C. DeWeirdt,et al. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection , 2020, Cell.
[11] W. Lim,et al. Dexamethasone in Hospitalized Patients with Covid-19 , 2021 .
[12] J. Bloom,et al. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2–induced systemic toxicity , 2020, JCI Insight.
[13] Yong-Gang Yao,et al. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19 , 2020, Signal Transduction and Targeted Therapy.
[14] H. Peckham,et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission , 2020, Nature Communications.
[15] G. Cappellano,et al. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 , 2020, International journal of molecular sciences.
[16] F. Cheng,et al. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 , 2020, PLoS biology.
[17] R. Malekzadeh,et al. Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results , 2020, medRxiv.
[18] Min Zheng,et al. A systematic review of SARS-CoV-2 vaccine candidates , 2020, Signal Transduction and Targeted Therapy.
[19] Jennifer G. Abelin,et al. SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs , 2020, bioRxiv.
[20] E. Piver,et al. The Role of Phosphatidylinositol Phosphate Kinases during Viral Infection , 2020, Viruses.
[21] T. Ideker,et al. Functional Landscape of SARS-CoV-2 Cellular Restriction , 2020, bioRxiv.
[22] T. Tuschl,et al. Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells , 2020, bioRxiv.
[23] Ruth Nussinov,et al. Artificial intelligence in COVID-19 drug repurposing , 2020, The Lancet Digital Health.
[24] P. Shi,et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age , 2020, PLoS biology.
[25] S. Ciesek,et al. Targeting pentose phosphate pathway for SARS-CoV-2 therapy , 2020, bioRxiv.
[26] Arti T. Navare,et al. Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality , 2020, The Journal of cell biology.
[27] Yong Wang,et al. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 , 2020, Protein & Cell.
[28] Kathleen M. Jagodnik,et al. The COVID-19 Drug and Gene Set Library , 2020, Patterns.
[29] Eytan Ruppin,et al. Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning , 2020, Nature.
[30] Matan Hofree,et al. The SARS-CoV-2 Transcriptional Metabolic Signature in Lung Epithelium , 2020 .
[31] F. Cheng,et al. A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19 , 2020, ChemRxiv : the preprint server for chemistry.
[32] Roland Eils,et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis , 2020, Nature Biotechnology.
[33] S. Fonseca,et al. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse , 2020, Frontiers in Immunology.
[34] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[35] E. Hod,et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. , 2020, JCI insight.
[36] M. Mann,et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV , 2020, Nature.
[37] L. Dodd,et al. Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.
[38] S. Ciesek,et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets , 2020, Nature.
[39] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[40] Lin Cheng,et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.
[41] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[42] M. Tay,et al. The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.
[43] Jean Thierry-Mieg,et al. Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions , 2020, bioRxiv.
[44] Huanhuan Gao,et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.
[45] Yan Liu,et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.
[46] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[47] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[48] M. Shi,et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients , 2020, Emerging microbes & infections.
[49] Edith Le Floch,et al. Clustering and variable selection evaluation of 13 unsupervised methods for multi-omics data integration , 2019, Briefings Bioinform..
[50] Luis Tobalina,et al. rMTA: robust metabolic transformation analysis , 2019, Bioinform..
[51] Gennady Korotkevich,et al. Fast gene set enrichment analysis , 2019, bioRxiv.
[52] G. Zlabinger,et al. Hijacking the Supplies: Metabolism as a Novel Facet of Virus-Host Interaction , 2019, Front. Immunol..
[53] Gi Bae Kim,et al. Current status and applications of genome-scale metabolic models , 2019, Genome Biology.
[54] E. Ruppin,et al. Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility , 2019, Neuron.
[55] Dong Yang,et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target , 2019, Nature Communications.
[56] J. Chan,et al. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication , 2019, Viruses.
[57] Christoph Hafemeister,et al. Comprehensive integration of single cell data , 2018, bioRxiv.
[58] K. Allegaert,et al. (Preprint) , 2018 .
[59] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[60] Henning Hermjakob,et al. The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..
[61] Daniel C. Zielinski,et al. Recon3D enables a three-dimensional view of gene variation in human metabolism , 2018 .
[62] Eytan Ruppin,et al. An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer , 2017, Molecular systems biology.
[63] Rob Patro,et al. Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.
[64] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[65] P. Linsley,et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.
[66] M. Lagunoff,et al. Viral activation of cellular metabolism. , 2015, Virology.
[67] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[68] Charity W. Law,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[69] Eytan Ruppin,et al. Model-based identification of drug targets that revert disrupted metabolism and its application to ageing , 2013, Nature Communications.
[70] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[71] D. Martens,et al. Genome-scale metabolic models: reconstruction and analysis. , 2012, Methods in molecular biology.
[72] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[73] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[74] Pedro M. Valero-Mora,et al. ggplot2: Elegant Graphics for Data Analysis , 2010 .
[75] Luis Serrano,et al. Correlation of mRNA and protein in complex biological samples , 2009, FEBS letters.
[76] Markus J. Herrgård,et al. Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.
[77] Herbert Stegemann,et al. [The International Clinical Trials Registry Platform - ICTRP]. , 2007, Archivos latinoamericanos de nutricion.
[78] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[79] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[80] J. Samet,et al. Food and Drug Administration , 2007, BMJ : British Medical Journal.